Home >Sponsored >New and innovative devices from aneurysms to radial access - one-year Experience with the Pipeline™ Vantage with Shield Technology™ and early re...

New and innovative devices from aneurysms to radial access - one-year Experience with the Pipeline™ Vantage with Shield Technology™ and early results using the Rist™ device

From LINNC Paris 2022, join Dr Saleh Lamin as he discusses with Dr Riitta Rautio about the Pipeline™ Vantage with Shield Technology™ and early experience in 100 patients using the Rist™ device for radial access.

With the introduction of the 0.021” system with longer catheters and implant diameters – previously not available for the Pipeline™ Shield – the Pipeline™ Vantage with the proven Shield Technology™ offers performance enhancements that increase reliability with improved visibility, easier opening and trackability, and with good occlusion results. What does the Pipeline™ Vantage offer for your interventions? For Dr Rautio the answer is clear, the compatibility with 0.021 means safer access more distally than ever before when treating aneurysms.

And introducing Rist™ – an innovative radial access device that your patients – and cath lab staff – will be asking for! Find out why, as Dr Rautio presents her initial experience in this revealing discussion…

READ & SHARE TOPIC

Addressing P1 Occlusion: A Successful Distal Thrombectomy

View

READ & SHARE TOPIC

M1 occlusion with persistent MeVO

View

READ & SHARE TOPIC

Double MeVO treated with Solitaire™ 3 mm

View

INTERVIEW

INPIREd by data: Learnings from INSPIRE-A and INSPIRE-S REGISTRIES

View

READ & SHARE TOPIC

Thrombectomy - When a small succeeds where a big cannot

View